Late-Life Depression
7
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.3%
1 terminated out of 7 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Effects of Specific Amino Acid Supplementation and Lifestyle Factors on Brain Ageing
Nitrous Oxide for Late-Life Depression - PROTO-BRAIN
Effects of Mindfulness or Brain Stimulation Intervention for Late-life Adults in Taiwan Urban and Rural Areas
Cognitive Behavioural Therapy for the Treatment of Late Life Depression
SSM vs HEP in Late-Life Depression
Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression
Fish Oil Supplementation in Late-life Depression